These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 5568810

  • 1. Biotransformation of diphenoxylate in rat and dog.
    Karim A, Garden G, Trager W.
    J Pharmacol Exp Ther; 1971 Jun; 177(3):546-55. PubMed ID: 5568810
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and metabolism of diphenoxylate in man.
    Karim A, Ranney RE, Evensen KL, Clark ML.
    Clin Pharmacol Ther; 1972 Jun; 13(3):407-19. PubMed ID: 5026379
    [No Abstract] [Full Text] [Related]

  • 3. Difenoxine (R15403), the active metabolite of diphenoxylate (R1132). 1. The excretion and metabolism in rats of difenoxine, the pharmacologically active metabolite of the antidiarrheal agent diphenoxylate.
    van Wijngaarden I, Soudijn W.
    Arzneimittelforschung; 1972 Mar; 22(3):513-6. PubMed ID: 5067919
    [No Abstract] [Full Text] [Related]

  • 4. Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 4. Distribution in the rat of diphenoxylate and difenoxine.
    Heykants JJ, Lewi PJ, Janssen PA.
    Arzneimittelforschung; 1972 Mar; 22(3):520-6. PubMed ID: 5067922
    [No Abstract] [Full Text] [Related]

  • 5. Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 6. Absorption, excretion and metabolism in man.
    Heykants J, Brugmans J, Verhaegen H.
    Arzneimittelforschung; 1972 Mar; 22(3):529-31. PubMed ID: 5067923
    [No Abstract] [Full Text] [Related]

  • 6. Absorption, distribution, biotransformation, and excretion of azidocillin, a new semi-synthetic penicillin, in mice, rats and dogs.
    Ramsay CH, Bodin NO, Hansson E.
    Arzneimittelforschung; 1972 Nov; 22(11):1962-70. PubMed ID: 4633590
    [No Abstract] [Full Text] [Related]

  • 7. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.
    Hucker HB, Grady LT, Michniewicz BM, Stauffer SC, White SE, Maha GE, McMahon FG.
    J Pharmacol Exp Ther; 1971 Nov; 179(2):359-71. PubMed ID: 5002483
    [No Abstract] [Full Text] [Related]

  • 8. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ, Chando TJ, Weliky I, Schreiber EC.
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract] [Full Text] [Related]

  • 9. [Animal experiments on pharmacokinetic and biotransformation of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].
    Duhm B, Maul W, Medenwald H, Patzschke K, Wegner LA.
    Arzneimittelforschung; 1972 Jan; 22(1):42-53. PubMed ID: 5066997
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism and disposition of methylphenidate-14C: studies in man and animals.
    Faraj BA, Israili ZH, Perel JM, Jenkins ML, Holtzman SG, Cucinell SA, Dayton PG.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):535-47. PubMed ID: 4473537
    [No Abstract] [Full Text] [Related]

  • 11. The metabolism of tinidazole in the rat and dog.
    Wood BA, Rycroft D, Monro AM.
    Xenobiotica; 1973 Dec; 3(12):801-12. PubMed ID: 4786681
    [No Abstract] [Full Text] [Related]

  • 12. [Biotransformation of prenylamine in rats].
    Volz M.
    Arzneimittelforschung; 1971 Sep; 21(9):1320-9. PubMed ID: 5171786
    [No Abstract] [Full Text] [Related]

  • 13. The disposition of butriptyline in rats, dogs and man.
    Cameron BD, Chasscaud LF, Lewis JD, Taylor T.
    Arzneimittelforschung; 1974 Jan; 24(1):93-6. PubMed ID: 4406119
    [No Abstract] [Full Text] [Related]

  • 14. The biologic disposition of pentazocine in the rat.
    el-Mazati AM, Way EL.
    J Pharmacol Exp Ther; 1971 May; 177(2):332-41. PubMed ID: 5568791
    [No Abstract] [Full Text] [Related]

  • 15. The metabolism of chlorpheniramine maleate in the dog and rat.
    Peets EA, Weinstein R, Billard W, Symchowicz S.
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):172-90. PubMed ID: 5072184
    [No Abstract] [Full Text] [Related]

  • 16. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.
    Karim A, Ranney RE, Kraychy S.
    J Pharm Sci; 1972 Jun; 61(6):888-93. PubMed ID: 5046104
    [No Abstract] [Full Text] [Related]

  • 17. Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.
    Dreyfuss J, Ross JJ, Schreiber EC.
    J Pharm Sci; 1971 Jun; 60(6):829-33. PubMed ID: 5128931
    [No Abstract] [Full Text] [Related]

  • 18. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W, Hendrickx J, Lauwers W, Swysen E, Hurkmans R, Knaeps F, Woestenborghs R, Heykants J.
    Drug Metab Dispos; 1984 Jun; 12(6):772-81. PubMed ID: 6150829
    [Abstract] [Full Text] [Related]

  • 19. [Resorption, excretion and biotransformation in dogs and rabbits, biotransformation in man of (methyl-10 phenothiazinyl-2) acetic acid (methiazinic acid--16091 R. P)].
    Populaire P, Terlain B, Pascal S, Lebreton G, Decouvelaere B.
    Arzneimittelforschung; 1969 Aug; 19(8):1214-21. PubMed ID: 5820286
    [No Abstract] [Full Text] [Related]

  • 20. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
    Musa MN, Lower GM, Welling PG, Johnson BM, Kaiman BD, Bryan GT.
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.